[Treatment of rheumatoid arthritis with levamisole].
D000293:Adolescent; D000328:Adult; D000368:Aged; D000844:Ankylosis / Q000628:therapy; D001172:Arthritis, Rheumatoid / Q000188:drug therapy* / Q000276:immunology; D001327:Autoimmune Diseases; D001799:Blood Sedimentation; D002986:Clinical Trials as Topic; D005260:Female; D005500:Follow-Up Studies; D006386:Hemagglutination Tests; D006801:Humans; D007153:Immunologic Deficiency Syndromes / Q000276:immunology; D007841:Latex Fixation Tests; D007978:Levamisole / Q000009:adverse effects / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D059408:Pain Management; D012217:Rheumatoid Factor / Q000032:analysis; D013585:Synovitis / Q000628:therapy; D013601:T-Lymphocytes / Q000276:immunology
D007978:Levamisole; D012217:Rheumatoid Factor
Le traitement de la polyarthrite rhumatoïde par le lévamisole